openPR Logo
Press release

Global Spinal Muscular Atrophy Market to grow at a CAGR of 14% in the coming years

03-12-2019 12:19 PM CET | Health & Medicine

Press release from: Renub Research

spinal-muscular-atrophy-market-countries-companies-forecast

spinal-muscular-atrophy-market-countries-companies-forecast

For More Information:
https://www.renub.com/global-spinal-muscular-atrophy-market-nd.php

Get Free Customization in This Report

Spinal muscular atrophy (SMA) is one of the most common genomic disorders which are caused due to the loss of specialized nerve cells known as motor neurons in the brainstem and spinal cord. The impairment of motor neurons leads to the weakness and atrophy of muscles used for the regular activities like crawling, sitting, walking and the head movement. In worst cases, the muscles used for breathing and swallowing also get affected. On the basis of severity of muscle weakness, the age of disease commencement, there are four types of spinal muscular atrophy namely type 1, type 2, type 3 and type 4. Type 1, 2 and 3 of spinal muscle atrophy appears in childhood while type 4 appears in adulthood. According to Renub Research forecast the global Spinal Muscular Atrophy Market to grow at a CAGR of 14% in the coming years. This high growth rate is primarily due to good reimbursement options in western countries, declining drug prices and projected launch of new drugs.

One of the major growth drivers witnessing the growth of spinal muscular atrophy market is growing awareness of diagnosis and treatment of spinal muscular atrophy during the forecast period. The awareness about the spinal muscular atrophy diagnosis and treatment is growing among the patients. The recent outcome of spinal muscular atrophy treatment further plays a significant role in spreading awareness about the disease.

Request a free sample copy of the report: https://www.renub.com/contactus

Additionally, increasing government and non-government support for the treatment and diagnosis of spinal muscular atrophy further boost the growth Global Spinal Muscular Atrophy Market over the coming years. The government of several countries across the world has developed regulations to help medical professionals and caregivers decide when to administer the cure to the infants with spinal muscular atrophy. For instance: In 2018, the Canadian organization of rare disorders signed a petition for funding SPINRAZA for the treatment of Canadian patients with spinal muscular atrophy. Furthermore, one of the key factors attributing to the growth of the spinal muscular atrophy market is the rising investing by the key market players for the research and development of new and effective spinal muscular atrophy therapies.

Spinal muscular atrophy generally shows its symptoms in early childhood and is a prime cause of mortality in infants. According to Spinal Muscular Atrophy (SMA) Foundation 2015 statistics, spinal muscular atrophy has been affected nearly 10,000 to 25,000 children and adults in the United States. The rising incidence of damaged spinal muscular atrophy gene amongthe infants around the world is expected to boost the growth of spinal muscular atrophy in the next couple of years. On the other hand, the high cost of drugs and treatment is likely to restrain the growth of spinal muscular atrophy market over the forecast period. For example, Biogen’s Spinraza (nusinersen) medicine for spinal muscular atrophy (SMA) is estimated to cost US$ 125,000 per injection, accounting huge expense for the treatment.

Client can Purchase this Report in Sections from below link:
Access full Research: https://www.renub.com/spinal-muscular-atrophy-market-p.php

Market Summary
• Country-wise, the report provides the Spinal muscular atrophy market and market share of United States, United Kingdom, France, Germany, Spain, Italy and Japan.
• Number of Patients-wise the report provides the total & treated patients population and population share of United States, United Kingdom, France, Germany, Spain, Italy and Japan.
• Drug-wise, the report provides present and estimated global sales of Spinraza, AVXS-101, CK2127107, RG7916, Olesoxime & LMI070.
• Company-wise the report provides present and estimated global of Biogen Inc., Roche AG, Novartis AG andCytokinetics Inc.
• Drugs Clinical Phase Study, The report provides 113 Drugs clinical study pipeline status Which is at present, globally in the various stage such as (Phase I, II and III) unknown status, recruiting, active, not recruiting, terminated or completed stage.

If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team at info@renub.com

Key Topics Covered :
1. Introduction
2. Research Methodology
3. Executive Summary
4. Global Spinal Muscular Atrophy Market and Patients Analysis
5. Share Analysis – Global Spinal Muscular Atrophy
6. United States
7. United Kingdom
8. Germany
9. Italy – Spinal Muscular Atrophy
10. France – Spinal Muscular Atrophy
11. Spain
12. Japan
13. Drugs Sales – Spinal Muscular Atrophy
14. Spinal Muscular Atrophy Study Status Analysis
15. Growth Drivers
16. Challenges
17. Biogen Inc.
18. Novartis AG
19. Roche Holding AG
20. Cytokinetics, Inc.

Contact Us
Email: info@renub.com
Phone: +1-678-302-0700
Web: www.renub.com

Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.

Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today's ultra-competitive markets.

225 Kristie Ln, Roswell, GA 30076, United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Spinal Muscular Atrophy Market to grow at a CAGR of 14% in the coming years here

News-ID: 1647392 • Views: 450

More Releases from Renub Research

Global Auto-Injector Market will be US$ 5.8 Billion by 2026
According to the latest report by Renub Research, titled "Auto-Injectors Market Global Forecast by Regions, Application (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others), Product Types, Distribution Channels, Company Analysis" The autoinjector is a small device which helps to deliver a fixed dose of a particular drug. These are typically spring-loaded syringes, which are specifically designed for the drug's convenience and secure dispensation. The market for Auto-injectors has grown significantly in the
Modified Starch Market will be US$ 14.9 Billion by 2026
According to the latest report by Renub Research, titled "Modified Starch Market, Production & Forecast, Sectors (Corn, Wheat, Cassava, Potato), Regions, Segments, Company Analysis" Modified starch is formed by morphological or physicochemical changes to the structure of native starch, through its treatment with heat, acids, alkalis, and enzymes. This treatment increased the capacity for water retention, heat resistance, binding features, and thickening properties. Some of the primary raw materials from
United States Modular Kitchen Market will be US$ 9 Billion by 2026
According to the latest report by Renub Research, titled "United States Modular Kitchen Market, By Design, Distribution Channels (Online, Offline), Products (Tall Storage, Floor Cabinet, Wall Cabinet), Regions, & Company Analysis" Modular kitchen market is growing in the United States due to an increase in a number of housing units, increasing demand for premiumization, shifting customer preference, growing collaborations between contractors and developers of real estate projects, a growing number
Netherlands Diabetes Market will be USD 4.48 Billion by 2025
According to the latest report by Renub Research, titled "Netherlands Diabetes Market, By Blood Glucose (SMBG) Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, Reimbursement Company Analysis & Forecast" The prevalence of diabetes mellitus (DM) is proliferating in the Netherlands. Country’s diabetes care is largely focused on primary health care, with the responsibility of general practitioners for most areas of care. The rise in the prevalence of obesity is

All 5 Releases


More Releases for Spinal

Spinal Fusion Market Foraying into Emerging Economies
Future Market Insights (FMI) offers a 10-year forecast of the global spinal fusion market. The primary objective of the report is to offer updates and information related to market opportunities in the global spinal fusion market as well as insights on the market dynamics that can influence the growth of the global spinal fusion market over the forecast period. Report overview @ https://www.xploremr.com/report/1047/spinal-fusion-market Insights on key trends, drivers, restraints, value forecasts
Spinal Non-Fusion
Spinal implants are devices used for the treatment of spinal disorders such as disproportion and instability of spine. Spine surgical devices are broadly classified into fusion and non-fusion devices. Fusion devices heals by providing immediate and rigid immobilization, and non-fusion devices treats by replacing pro-inflammatory tissues, restoring spinal alignment, and decompressing neural elements while preserving functional movements rather than obliterating it. The advantages such as prolonged recuperation time, bone graft
Spinal Trauma Devices Market: Spinal Trauma Devices Sales to Surge Rapidly in Re …
The global spinal trauma devices market is dynamic and highly competitive. Only a couple of companies account for a substantial share in the market, thus lending it an oligopolistic vendor landscape. The market is largely dominated by DePuy Synthes, Medtronic, NuVasive, Inc., Stryker Corporation, and Globus Medical, Inc. The cumulative share of these companies added up to 79.1% in 2014, says Transparency Market Research (TMR) in a new report. As
Spinal Fusion - Current and Future Players
ReportsWorldwide has announced the addition of a new report title Spinal Fusion - Current and Future Players to its growing collection of premium market research reports. The spinal fusion market is an established orthopedic market that has witnessed sluggish revenue growth in the past five years. GlobalData evaluated the currently-marketed spinal fusion implants, identified the unmet needs in the market, and provided an understanding of surgeons’ perceptions of the latest advances,
Global Spinal Implants Sales Market Report 2021
Global Spinal Implants Industry 2016 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2016-2020. The market intelligence publication delves into the condition of the global Spinal Implants market. An in-depth examination of the existing market state, past progress, and forthcoming prospects of the global Spinal Implants market has been presented in the research report. The research publication also reports the chief strategies,
Market Intelligence Report Spinal Fusion, 2015-2025
There are several huge aspects impacting medical device technology field nowadays. A number of trends including consolidation, research and developments, and international strategies and alliances are driving the market for china spinal fusion market. The spinal fusion is one of the most common surgeries suggested for back problems. With the increasing spinal fusion surgery volumes in china due to the favourable reimbursement levels and patients’ willingness to undergo surgery with